IDiyas

For the Inventor, By the Inventor

Reedsport, OR, United States of America

Alexander B Rossi

USPTO Granted Patents = 39 


 

Average Co-Inventor Count = 7.8

ph-index = 19

Forward Citations = 1,757(Granted Patents)


Location History:

  • San Francisco, CA (US) (2005 - 2015)
  • Reedsport, OR (US) (2009 - 2021)

Company Filing History:

goldMedal37 out of 488 
 
Rigel Pharmaceuticals, Incorporated
 patents
silverMedal1 out of 1 
 
Rogel Pharmaceuticals, Inc.
 patent
bronzeMedal1 out of 1 
 
Rigel, Inc.
 patent

Years Active: 2005-2021

Loading Chart...
Loading Chart...
Loading Chart...
39 patents (USPTO):
1. 11007193 - 2,4-pyrimidinediamine compounds and their uses (2021-05-18),
2. 10828301 - 2,4-pyrimidinediamine compounds and their uses (2020-11-10),
3. 10709703 - 2,4-pyrimidinediamine compounds and their uses (2020-07-14),
4. 10682350 - 2,4-pyrimidinediamine compounds and their uses (2020-06-16),
5. 10369148 - 2,4-pyrimidinediamine compounds and their uses (2019-08-06),
6. 10314840 - 2,4-pyrimidinediamine compounds and their uses (2019-06-11),
7. 9913842 - 2,4-pyrimidinediamine compounds and their uses (2018-03-13),
8. 9586908 - 2,4-pyrimidinediamine compounds and their uses (2017-03-07),
9. 9540334 - 2,4-pyrimidinediamine compounds and their uses (2017-01-10),
10. 9499493 - 2,4-pyrimidinediamine compounds and their uses (2016-11-22),
11. 9416112 - 2,4-pyrimidinediamine compounds and their uses (2016-08-16),
12. 9346765 - 2,4-pyrimidinediamine compounds and their uses (2016-05-24),
13. 9162989 - 2,4-Pyrimidinediamine compounds and their uses (2015-10-20),
14. 9133133 - 2,4-pyridinediamine compounds and their uses (2015-09-15),
15. 9040550 - 2,4-pyrimidinediamine compounds and their uses (2015-05-26),

Title: Innovations and Contributions of Alexander B. Rossi

Introduction

Alexander B. Rossi, based in Reedsport, OR, has made significant contributions to the field of pharmaceutical sciences with a remarkable portfolio of 39 patents. His innovative work primarily focuses on the development of compounds that hold therapeutic potential in the treatment and prevention of various diseases.

Latest Patents

Among his latest inventions, Rossi has developed 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades. These compounds are instrumental in controlling the release of chemical mediators associated with degranulation. His work outlines the synthesis, application methods, and therapeutic uses of these compounds, which include their role in treating diseases characterized by the activation of these signaling pathways.

Career Highlights

Rossi's professional journey includes stints at esteemed companies such as Rigel Pharmaceuticals and Rogel Pharmaceuticals. His work in these organizations has positioned him as a pivotal figure in pharmaceutical innovation, where he has been able to apply his expertise in drug development and molecular design.

Collaborations

During his career, Rossi has collaborated with notable professionals, including Donald G. Payan and Ankush Argade. These partnerships have further enhanced his innovative work and have led to advancements in the research and development of pharmaceutical compounds, fostering a collaborative environment that promotes scientific exploration.

Conclusion

With 39 patents to his name, Alexander B. Rossi continues to be a significant contributor to the innovation landscape in pharmaceuticals. His research on 2,4-pyrimidinediamine compounds showcases his dedication to improving health outcomes through scientific advancements. As he continues his work, his contributions will undoubtedly shape the future of therapeutic interventions in various medical fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…